Mannheim, Germany

Jochen Schulat

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 3.5

ph-index = 5

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 2009-2021

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Jochen Schulat: Innovator in Glucose Measurement Technologies

Introduction

Jochen Schulat is a prominent inventor based in Mannheim, Germany. He has made significant contributions to the field of medical technology, particularly in the area of glucose measurement and hematocrit correction. With a total of 12 patents to his name, Schulat's work has had a profound impact on diabetes management and patient care.

Latest Patents

Schulat's latest patents include innovative methods for correcting analyte concentration measurements influenced by hematocrit levels. One of his notable inventions involves methods for adjusting glucose concentration measurements by determining a hematocrit reference value from a blood sample. This process includes applying a fresh blood sample to a disposable analytical test element, measuring the glucose value, and adjusting it using a hematocrit correction value. Additionally, he has developed devices and methods for determining disturbance variable-corrected analyte concentrations, which enhance the accuracy of glucose measurements in body fluid samples.

Career Highlights

Throughout his career, Jochen Schulat has worked with leading companies in the medical diagnostics field, including Roche Diagnostics Operations, Inc. and Roche Diabetes Care, Inc. His experience in these organizations has allowed him to refine his expertise in developing advanced glucose measurement technologies.

Collaborations

Schulat has collaborated with notable professionals in his field, including Wilfried Schmid and Rudolf Pachl. These partnerships have contributed to the advancement of his innovative projects and the successful development of his patented technologies.

Conclusion

Jochen Schulat's contributions to glucose measurement and hematocrit correction have established him as a key figure in medical technology innovation. His work continues to influence the way diabetes is managed, improving the quality of life for many patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…